Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) gapped up prior to trading on Thursday . The stock had previously closed at $3.25, but opened at $3.43. Raia Drogasil shares last traded at $3.43, with a volume of 159 shares changing hands.
Raia Drogasil Stock Performance
The stock has a 50-day simple moving average of $3.56 and a 200 day simple moving average of $4.13.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.05. The firm had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.32 billion. Equities analysts forecast that Raia Drogasil S.A. will post 0.17 earnings per share for the current year.
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Further Reading
- Five stocks we like better than Raia Drogasil
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
